Application of the acetylcholinesterase inhibitor physostigmine to conventional hippocampal slices caused a significant reduction of field EPSPs elicited by single pulse stimulation to the medial perforant path. Similar but smaller effects were obtained in the lateral perforant path and other excitatory pathways within hippocampus. The reductions were blocked by atropine, not accompanied by evident changes in the EPSP waveform, and eliminated by lesions to the cholinergic septo-hippocampal projections.
. R2 FINAL ACCEPTED VERSION 5 diluted with aCSF to a final working concentration (4-8 µM) containing < 0.1% DMS0. Atropine solutions were prepared from salt on the day of the experiment.
Fornix/fimbria lesion and acetylcholinesterase histochemistry. For ablation of cholinergic septal afferents, 4-5 week old male Sprague Dawley rats were anesthetized with ketamine and xylazine (50 mg/kg and 10 mg/kg, respectively; i.p.), and a window of bone overlying the septal pole of hippocampus was removed. A drawn glass aspiration pipette was used to remove the neocortex overlying the anterior tip of hippocampus and then to ablate the fimbria/fornix anterior and medial to this level. There was some variable damage to the septal nuclei. At 5-10 days post-lesion, the rats were killed and the hippocampus ipsilateral to the lesion was used for preparation of acute hippocampal slices and electrophysiological recordings, carried out as described above. The slices were then fixed in 4% paraformaldehyde (0.5-2d, 4 o C), sectioned at 30 µm parallel to the surface of the slice, and processed free floating for histochemical localization of actylcholinesterase using a modification of methods of Koelle and Friedenwald (1949) (Broide et al. 1996; Mosko et al. 1973) . Sections were incubated in a tetraisopropylpyrophosphoramide / acetylthiocholide iodide solution overnight at room temperature and developed in 1% ammonium sulfide for 45 seconds.
Data analysis. Student's t-tests were carried out to determine statistical significance of the results. Data are presented as mean ± S.E.M. responses beginning 10-15 minutes after the start of infusion with maximum effects appearing over the following 30 minutes. In the apparatus used in the present experiments, compounds added to the infusion lines require about 5 minutes to reach the slices and an additional several minutes to reach their maximum bath concentration. The field EPSP depression was modest in size, did not appear to be accompanied by distortions of waveform (Fig. 1C) , and was reliably larger for the medial than for the lateral perforant path (-26 ± 4 % vs -9 ± 2%, mean ± S.E.M., at 40-50 min after the start of infusion; p < 0.004, 2-tailed t-test) (Fig. 1, A and B) . The threshold physostigmine concentration for reliable reductions was about 1µM (data not shown), and the effects of physostigmine were blocked by atropine at 10µM (Fig. 1D) .
Results

Fig
The above effects were not restricted to the dentate gyrus. Physostigmine caused reliable depressions in field EPSPs elicited by stimulation of Schaffer-commissural afferents to field CA1 ( Fig.   2A ), consistent with in vitro reports involving application of ACh (Hasselmo and Fehlau 2001). There were no reliable alterations in mossy fiber responses (Fig. 2B) , which is not unexpected given a recent report indicating that the agonist muscarine does not directly affect mossy fiber transmission (Vogt and Regehr 2001 ). It appears then that physostigmine's effects, although especially large in the medial perforant path, are not restricted to the dentate gyrus. Figure 3 illustrates the results obtained in hippocampal slices prepared from rats in which the septo-hippocampal fibers had been severed by ablation of the fimbria/fornix at the level of the hippocampal commissure. Surgery was carried out at least 5 days prior to physiological recording to allow the septal projections to degenerate; the delay was sufficient to cause the loss of virtually all AChE staining at the time of testing (Fig. 3B) . Field EPSPs appeared normal in the denervated slices and, as shown in Fig. 3C and D, were unaffected by physostigmine.
The low concentrations of physostigmine used to depress perforant path responses did not appear to affect the excitability of the post-synaptic granule cells. The amplitude of the antidromic population spike elicited by stimulation of the mossy fibers was not measurably changed ( recorded were indeed activated antridromically was provided by the observation that they reliably followed high frequency trains of stimulation (Fig. 4B ).
The absence of evident post-synaptic changes, or alterations in the shape of the fEPSP waveform, points to the conclusion that physostigmine reduces synaptic responses by depressing release. Paired pulse facilitation, a simple and sensitive measure of changes in release probability, was used to test this hypothesis (Fig. 5) . Mean paired pulse facilitation of lateral perforant path responses was increased by low (1 µM) concentrations of physostigmine, but the effects were variable and did not reach statistical significance. A 5 µM concentration of the drug reliably enhanced paired pulse facilitation in the lateral perforant path with the same infusion time-course over which field EPSPs were reduced. Mean facilitation of the response slope was 29 ± 3% before physostigmine (5 µM) and 46 ± 5% at the end of infusion (p < 0.02); comparable values for response amplitude were 30 ± 3% and 41 ± 2% (p < 0.009).
Extensive electron microscopic analyses have determined that axo-axonic contacts are rare in the molecular layer of the dentate gyrus while cholinergic (i.e., choline acetyltransferase and/or AChE positive) terminals in that region are reported to form dendritic contacts (Cotman et al., 1973; Clarke 1985; Frotscher and Leranth 1985) . (Shen et al. 1996; Ameri et al. 1999; Sullivan 1999; Gerdeman and Lovinger 2001; Hajos et al. 2001) . Moreover, there is good evidence that cholinergic stimulation in the hippocampus initiates endocannabinoid release (Kim et al. 2002) . The selective CB1 antagonist AM251 was used to test if cannabinoid receptors mediate the effects of physostigmine on perforant path responses in the dentate gyrus. As shown in Fig. 6A and B, physostigmine had no effect on medial or lateral perforant path field EPSPs in slices pretreated with a cannabinoid receptor antagonist. Because AM251 is dissolved in JN-00262-2003 . R2 FINAL ACCEPTED VERSION 8 DMSO, control slices were treated with DMSO at the same concentration; in these cases, physostigmine produced decreases that were comparable to those obtained with physostigmine alone (20 ± 9 % amplitude decrease for DMSO slices at end of 30 minute physostigmine infusion, n = 3). To ensure that the lack of a physostigmine effect was not related to reported interactions between CB1 activation and GABA-A receptor-mediated inhibition (e.g., Hoffman and Lupica 2000), the experiments with AM251
were repeated in the presence of the GABA-A antagonist picrotoxin (PTX). As shown in Fig. 6C , incubation of slices with PTX did not affect the ability of AM251 to block physostigmine-induced depression of medial perforant path responses.
Combined immunocytochemistry and electron microscopy studies have found m2 type muscarinic receptors in a minority of axon terminals in the middle molecular layer of the dentate gyrus (Rouse et al. 1998 ). To test if physostigmine's effects at the medial perforant path synapse are mediated by m2 receptors, slices were treated with the selective antagonist, methoctramine. As shown in Fig. 6D , methoctramine did not prevent the physostigmine-induced reduction of the medial perforant path response. In control slices treated with methoctramine alone, the drug produced small and insignificant increases in medial perforant path responses.
Discussion
The above results suggest that the cholinergic projections from septum to hippocampus reduce release from glutamatergic terminals and thereby depress fast excitatory transmission. Low to moderate concentrations of physostigmine caused a rapid reduction in perforant path responses and an increase in paired pulse facilitation. The latter effect constitutes strong evidence for depressed release and suggests that this effect accounts for the synaptic depression produced by physostigmine. In agreement with this, the AChE inhibitor caused no evident post-synaptic changes. That the drug's actions on glutamatergic synapses were due to enhanced transmission at septo-dentate synapses was confirmed by showing that the JN-00262-2003 . R2 FINAL ACCEPTED VERSION 10 hippocampal responsivity so as to favor inputs synchronized to either of these two firing patterns. It is noteworthy that cholinergic stimulation triggers beta and gamma oscillations in entorhino-hippocampal slices (Fisahn et al. 1998; Shimono et al. 2000; Colgin et al. 2003) .
The effects of physostigmine were significantly larger for medial perforant path responses than for responses to other hippocampal projections. This could be related to the densities and distributions of cholinergic afferents across the different hippocampal subfields. As can be seen in figure 2 and described elsewhere (Mosko et al. 1973; Storm-Mathisen 1977; Lynch et al. 1977) , cholinergic afferents are more numerous in the middle molecular layer (the terminus of the medial perforant path) than in the more distal lateral perforant path zone, and significantly denser in these two lamina of stratum moleculare than in stratum radiatum of hippocampus proper. An additional possibility exists that the greater sensitivity of the medial perforant path to physostigmine relates to the peculiar paired pulse depression effect exhibited by that pathway (McNaughton 1980 ). This could be tested by assessing the effects of physostigmine on slices of piriform cortex, where facilitation and depression are also found in adjacent pathways (Hasselmo and Bower 1990).
Physostigmine's depression of perforant path responses was blocked by atropine, indicating that the effect is mediated by muscarinic ACh receptors. There are at least four subtypes of muscarinic receptors (m1-m4) found in the septal innervation zones of hippocampus (Levey et al. 1995) . Two of these subtypes (m2 and m4) have been localized to perforant pathway terminals, leading to the suggestion that cholinergic input from the septum could shut down glutamate release at the perforant path via a heteroreceptor mechanism (Rouse et al. 1998 ). However, electron microscopic analyses have failed to uncover evidence for axoaxonic synapses between septal and perforant path fibers in the molecular layer of the dentate gyrus (Cotman et al. 1973; Clarke 1985; Frotscher and Leranth 1985) , and i t is questionable whether diffusion of ACh from the sparsely scattered septal endings could significantly affect a far more numerous population of perforant path synapses. In this regard, it is important to note JN-00262-2003 . R2 FINAL ACCEPTED VERSION 12 points to pre-synaptic localization of the receptors in the molecular layer (Mailleux and Vanderhaeghen 1992) . In agreement with this, in situ hybridization analyses have shown that CB1, along with cholecystokinin (CCK), is also expressed at low but significant levels by entorhinal layer II projection neurons that innervate the dentate gyrus (Marsicano and Lutz 1999).
In summary, facilitation of the cholinergic septo-hippocampal synapses causes a substantial depression of release from one of the major inputs to hippocampus (the medial perforant path) and lesser reductions in excitatory transmission at other sites within the structure. These effects appear to involve retrograde actions (post-synaptic to pre-synaptic) of cannabinoids. The results provide a new description of how septal projections alter operations within hippocampus and, coupled with the potent effects of cholinergic inputs on rhythm production (Petsche et al. 1962; Gogolak et al. 1968; Stewart and Fox 1989) , suggest that their actions may serve to favor particular temporal patterns of input from cortex. summarizes group data contrasting the magnitude of physostigmine-induced depression of medial perforant path responses in control slices with the complete lack of a physostigmine effect in slices cut from lesioned animals (n= 7 and 6 for control and lesion cases, respectively). 
